Taysha Gene Therapies, Inc.

Taysha Gene Therapies (TSHA) After Early Rett Data With An Undervalued Narrative
Simply Wall Street · 20 Oct 2026
Taysha Gene Therapies stock hits 52-week low at 3.69 USD
Investing.com · 13 Oct 2026
Taysha Gene Therapies (TSHA) Slips 3.59% to $4.46 as Shares Drift Toward Near-Term Support - Factor Valuation
https://www.dars.gov.et/ · 05 Oct 2026
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · 02 Oct 2026
Four new hires get Taysha stock awards tied to 384,000 shares, plus rights to buy more.
Stock Titan · 02 Oct 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →

Disclaimer — PositoAI is a research and screening tool for educational and informational purposes. It is not investment advice or a recommendation to buy or sell any security or mutual fund. Scores and rankings are calculated by PositoAI's own method using publicly available data, which may be incomplete, delayed or inaccurate, and past performance does not indicate future results. AI summaries of company news may contain errors. PositoAI is not registered with the SEC, SEBI or any other regulatory authority. Please do your own research or consult a licensed financial advisor before investing.